Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;145(8):918-22.
doi: 10.1001/archdermatol.2009.78.

Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease

Affiliations

Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease

Jason Clark et al. Arch Dermatol. 2009 Aug.

Abstract

Background: Sclerotic-type chronic graft-vs-host disease (cGVHD) of the skin is an uncommon but potentially debilitating sequela of allogeneic hematopoietic stem cell transplantation. There is no standardized assessment measure for this form of cGVHD. Because a full-thickness incisional biopsy specimen to the level of the fascia may be needed to make a definitive histologic diagnosis of cGVHD-related fasciitis, a noninvasive technique for the assessment and monitoring of sclerotic-type cGVHD, particularly cGVHD-related fasciitis, would be of potential value.

Observations: Sixty-two consecutive patients with cGVHD following allogeneic hematopoietic stem cell transplantation were evaluated for sclerotic skin disease. Forty-four patients (71%) had cutaneous cGVHD, and 28 patients (45%) had evidence of sclerotic involvement based on physical examination findings. Fifteen patients agreed to undergo research magnetic resonance imaging to evaluate quantifiable changes in the dermis, subcutaneous tissue, and muscle. Among 15 patients, magnetic resonance imaging identified abnormalities in the skin in 7 (47%), subcutaneous fibrous septa in 13 (87%), deep fascia in 12 (80%), epimysium in 9 (60%), and muscle in 3 (20%).

Conclusions: Magnetic resonance imaging should be considered in the evaluation of patients with cGVHD suspected of having subcutaneous or fascial involvement. Additional studies are needed to validate this noninvasive modality for serial monitoring of disease activity and response to therapy. Trial Registration clinicaltrials.gov Identifier: NCT00331968.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Fasciitis with overlying skin involvement in a 56-year-old man 37 months after allogeneic hematopoietic stem cell transplantation for multiple myeloma (patient 5 in Table 1 and Table 2). A, Erythema and induration on the anterolateral aspect of the right thigh. B, Axial T1-weighted spin-echo image demonstrates thickening of the skin, with intervening fat dropout (arrowheads) overlying a region of narrowing and sclerosis of the subcutis. There is also thickening of the adjacent superficial fascia (arrow). C, Axial 3-dimensional gradient recalled echo image after administration of contrast medium demonstrates mild enhancement of the skin and subcutis in the region of sclerosis, with more prominent and extensive enhancement along the deep fascia (arrows). Magnetic resonance imaging total score of 8 (score of 2 each for skin, septa, deep fascia, and epimysium).
Figure 2.
Figure 2.
Fasciitis without overlying superficial skin sclerosis in a 45-year-old man 26 months after allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia (patient 10 in Table 1 and Table 2). A, A subtle rippled appearance is present on the right medial thigh. A firm nodular texture was detected on deep palpation. B, Axial 3-dimensional gradient recalled echo (out-of-phase echo time) image demonstrates mild thickening of the subcutaneous septa (arrows) and minimal thickening of the deep fascia (arrowheads). C, Axial short tau inversion recovery image demonstrates widespread linear increased signal along the deep fascia (arrowheads) and along the epimysium of various muscles (arrows). Magnetic resonance imaging total score of 7 (score of 1 for skin and 2 each for septa, deep fascia, and epimysium).

Similar articles

Cited by

References

    1. Filipovich AH, Weisdorf D, Pavletic S, et al.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease, I: Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2005;11(12):945–956. - PubMed
    1. Hymes SR, Turner ML, Champlin RE, Couriel DR. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006;12(11):1101–1113. - PubMed
    1. Schaffer JV, McNiff JM, Seropian S, Cooper DL, Bolognia JL. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol. 2005;53(4):591–601. - PubMed
    1. Häusermann P, Walter RB, Halter J, et al.Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology. 2008;216(4):287–304. - PubMed
    1. Kimball AB, Summers RM, Turner M, et al.Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy. Arthritis Rheum. 2000;43(8):1866–1873. - PubMed

Publication types

Associated data